6/11, 1:31 PM (Source: TeleTrader)
more TeleTrader news

BioNTech secures €100M for vaccine program

BioNTech SE and the European Investment Bank (EIB) signed an agreement worth €100 million for the advancement of the company’s BNT162 coronavirus vaccine program, the European Commission stated in a press release on Thursday.

As the first company to have started clinical testing in Europe, BioNTech will also be awarded funding to expand its manufacturing capacity, the statement read.

The contract comes as part of the broader Coronavirus Global Response initiative, during which BioNTech teamed up with Pfizer Inc. to conduct vaccine trials in Germany in late April.

Breaking the News / BU